<div id="readability-page-1">MKS (NASDAQ:MKSI - Get Free Report) had its price target increased by stock analysts at Citigroup from $290.00 to $355.00 in a note issued to investors on Friday,Benzinga reports. The firm currently has a &#34;buy&#34; rating on the scientific and technical instruments company's stock. Citigroup's price objective would indicate a potential upside of 13.46% from the company's previous close.<ul><li>3 High-Growth Unknowns in Photonics That Are Vital for AI</li></ul>A number of other research analysts have also issued reports on MKSI. Cantor Fitzgerald raised their target price on shares of MKS from $300.00 to $400.00 and gave the company an &#34;overweight&#34; rating in a research note on Wednesday, April 22nd. Bank of America raised their target price on shares of MKS from $215.00 to $255.00 and gave the company a &#34;buy&#34; rating in a research note on Thursday, January 22nd. Wells Fargo &amp; Company raised their price target on shares of MKS from $255.00 to $300.00 and gave the stock an &#34;equal weight&#34; rating in a research report on Friday. Morgan Stanley restated an &#34;overweight&#34; rating and issued a $354.00 price target on shares of MKS in a research report on Thursday. Finally, JPMorgan Chase &amp; Co. raised their price target on shares of MKS from $305.00 to $365.00 and gave the stock an &#34;overweight&#34; rating in a research report on Friday. One equities research analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company. According to MarketBeat, MKS has a consensus rating of &#34;Moderate Buy&#34; and a consensus target price of $317.23.Read Our Latest Research Report on MKS<h2>MKS Stock Performance</h2><ul><li>The 3 Favored Machinery Stocks To Buy In August</li></ul>NASDAQ:MKSI traded up $12.10 during midday trading on Friday, reaching $312.89. The stock had a trading volume of 1,452,178 shares, compared to its average volume of 1,413,504. MKS has a 1-year low of $78.62 and a 1-year high of $326.83. The firm's fifty day simple moving average is $249.12 and its 200-day simple moving average is $205.60. The company has a debt-to-equity ratio of 1.53, a current ratio of 2.71 and a quick ratio of 1.71. The stock has a market capitalization of $21.06 billion, a P/E ratio of 65.46, a PEG ratio of 1.57 and a beta of 1.98. MKS (NASDAQ:MKSI - Get Free Report) last posted its earnings results on Wednesday, May 6th. The scientific and technical instruments company reported $2.30 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.00 by $0.30. MKS had a net margin of 8.06% and a return on equity of 21.88%. The business had revenue of $1.08 billion for the quarter, compared to analyst estimates of $1.05 billion. During the same period last year, the business posted $1.71 EPS. MKS's revenue was up 15.2% compared to the same quarter last year. MKS has set its Q2 2026 guidance at 2.600-3.200 EPS. On average, equities research analysts forecast that MKS will post 9.89 EPS for the current fiscal year. <h2>Insider Buying and Selling</h2>In other MKS news, EVP Eric Robert Taranto sold 4,568 shares of the firm's stock in a transaction on Friday, March 6th. The shares were sold at an average price of $220.52, for a total value of $1,007,335.36. Following the sale, the executive vice president directly owned 15,445 shares in the company, valued at $3,405,931.40. This trade represents a 22.83% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CEO John Tseng-Chung Lee sold 30,000 shares of the firm's stock in a transaction on Friday, February 20th. The stock was sold at an average price of $256.77, for a total transaction of $7,703,100.00. Following the completion of the sale, the chief executive officer owned 154,696 shares in the company, valued at $39,721,291.92. This represents a 16.24% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last ninety days, insiders sold 68,503 shares of company stock worth $17,288,099. 0.57% of the stock is currently owned by corporate insiders. <h2>Institutional Inflows and Outflows</h2>Several hedge funds have recently added to or reduced their stakes in MKSI. USA Financial Formulas acquired a new stake in MKS during the fourth quarter valued at approximately $26,000. Global Retirement Partners LLC boosted its holdings in MKS by 560.0% during the fourth quarter. Global Retirement Partners LLC now owns 165 shares of the scientific and technical instruments company's stock valued at $26,000 after purchasing an additional 140 shares in the last quarter. IFP Advisors Inc boosted its holdings in MKS by 616.7% during the fourth quarter. IFP Advisors Inc now owns 172 shares of the scientific and technical instruments company's stock valued at $27,000 after purchasing an additional 148 shares in the last quarter. Kestra Advisory Services LLC acquired a new stake in MKS during the fourth quarter valued at approximately $41,000. Finally, CIBC Private Wealth Group LLC boosted its holdings in MKS by 55.2% during the fourth quarter. CIBC Private Wealth Group LLC now owns 256 shares of the scientific and technical instruments company's stock valued at $41,000 after purchasing an additional 91 shares in the last quarter. Institutional investors and hedge funds own 99.79% of the company's stock. <h2>Trending Headlines about MKS</h2>Here are the key news stories impacting MKS this week:<ul> <li>Positive Sentiment: Q1 results and raised guidance: MKS reported Q1 EPS of $2.30 (vs. $2.00 est.) and revenue of $1.08B (vs. $1.05B est.), and issued Q2 EPS guidance of $2.60–3.20 and revenue guidance around $1.2B — all above Street expectations, supporting the stock's rally. GlobeNewswire: Q1 Results</li> <li>Positive Sentiment: Needham raised its price target to $360 and maintained a &#34;buy&#34; rating, signaling analyst confidence in upside from continued semiconductor/AI-driven demand. Street Insider: Needham PT Raise</li> <li>Positive Sentiment: JPMorgan raised its target to $365 and put an &#34;overweight&#34; rating on MKSI, providing another high‑profile vote of confidence that likely contributed to buying interest. Benzinga: JPMorgan PT Raise</li> <li>Neutral Sentiment: Earnings call transcript available — useful for parsing management commentary on AI-related demand, supply chain, and margin drivers to judge sustainability of the beat. Seeking Alpha: Q1 Call Transcript</li> <li>Neutral Sentiment: Analysts (Zacks and others) highlight that strength was driven by AI-related demand across semiconductor markets — a positive thematic driver but one that requires monitoring for cyclicality. Zacks: Earnings Beat Coverage</li> <li>Negative Sentiment: Wells Fargo raised its target to $300 but kept an &#34;equal weight&#34; rating — the PT implies modest downside vs. recent levels, signaling some analysts view limited near‑term upside and suggesting potential caution/price consolidation. Benzinga: Wells Fargo PT Raise</li> </ul><h2>About MKS</h2> (Get Free Report)MKS Instruments, Inc NASDAQ: MKSI designs, manufactures and markets technology solutions that enable advanced processes in a variety of high‐technology and industrial markets. The company's core offerings include vacuum and gas delivery systems, pressure and flow measurement instruments, optical metrology tools, photonics subsystems and critical components for manufacturing processes. These products support the precise control and monitoring needs of semiconductor, industrial manufacturing, life and health sciences, and research applications. The company's product portfolio features mass flow controllers, pressure transducers, vacuum gauges, gas purity monitors, laser-based metrology systems and photonic devices such as lasers and detectors.<h2>Featured Stories</h2><ul><li>Five stocks we like better than MKS</li></ul><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9TUtTSQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="330" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9TUtTSQ"/>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.<h2>Should You Invest $1,000 in MKS Right Now?</h2>Before you consider MKS, you'll want to hear this.MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MKS wasn't on the list.While MKS currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.View The Five Stocks Here </div>

MKSI

SOXX

Citigroup has raised its price target for MKS (NASDAQ:MKSI) from $290.00 to $355.00, maintaining a "buy" rating. This new target suggests a potential upside of 13.46% from the previous close. Other analysts have also increased their targets, with Cantor Fitzgerald setting it at $400.00 and JPMorgan at $365.00. MKS currently has a consensus rating of "Moderate Buy" and a target price of $317.23. The stock traded at $312.89, with a market cap of $21.06 billion and a P/E ratio of 65.46.

Market Beat

VanEck Semiconductor ETF

iShares Semiconductor ETF

Citigroup

Bank of America

Wells Fargo

Morgan Stanley

JPMorgan Chase

CITIGROUP INC 6.250 NON CUM SER II PFD WI

BANK OF AMERICA CORPORATION DEP SHS REP 1/1000TH INT NON CUM PFD QQ

BANK OF AMERICA CORPORATION DEP SHS REP 1/1200TH PRF SERIES '5'

BANK OF AMERICA CORPORATION 7.25% NON-CUM PERP CONV PFD SER L

BANK OF AMERICA CORPORATION 5.875%NON CUM DEP SHS REP1/1000TH SER HH

BANK OF AMERICA CORPORATION DEP SHS REP 1/1200TH PRF SERIES '2'

BANK OF AMERICA CORPORATION 5% DEP SHS REPR 1/1000TH NON CUM PFD LL

BANK OF AMERICA CORPORATION DEP SHARES REP 1/1000TH PERP PFD SER 'E'

BANK OF AMERICA CORPORATION INCOME CAPITAL OBLIG NTS DUE 15/12/2066

BANK OF AMERICA CORPORATION 4.375% DP SH RP 1/1000TH IN NON CU PF NN

BANK OF AMERICA CORPORATION DEP SH REP 1/1200TH PRF SER 1 USD25

BANK OF AMERICA CORPORATION 5.375%DEP SHS REP 1/1000TH NON CUM SR KK

BANK OF AMERICA CORPORATION 6%NON CUM DEP SHS EACH REP 1/1000 SER GG

BANK OF AMERICA CORPORATION DEP SHS REP 1/1200 PFD SER 4 USD25

BANK OF AMERICA CORPORATION DEP SHS REP 1/1000TH NON CUM PFD SER SS

BANK OF AMERICA CORPORATION 4.125%DEP SH REP 1/1000 PFD SER PP USD25

Bank of America Corp

WELLS FARGO & COMPANY DP SHS REP 1/1000TH INT NCUM PFD CL A DD

WELLS FARGO & COMPANY 7.5% PERP CONV PRF CLS 'A' SERIES 'L'

WELLS FARGO & COMPANY DEP SHS REP 1/1000 INT PER PFD SER Y A

WELLS FARGO & COMPANY DP SHS REP 1/1000TH INT NCUM PFD CL A CC

WELLS FARGO & COMPANY 4.75% DEP SHS 1/1000 NCUM PFD CL A SR Z

WELLS FARGO & COMPANY DEP SHS REP 1/1000TH INT PFD SR AA (CLA)

MORGAN STANLEY DEP SHS EA REP 1/1000 SHS NON CUM PFD O

MORGAN STANLEY DEP SHS REPSTG 1/1000TH PFD SER Q

MORGAN STANLEY DEP SHS REPS 1/1000 7.125% PFD E

MORGAN STANLEY NON-CUM DEP SH REP 1/1000 PFD SER I

MORGAN STANLEY 4.875 DEP SHS REP 1/1000 NCUM PFD SR L

MORGAN STANLEY 6.5%DEP SHS REPSTG 1/1000 NON CUM SER P

MORGAN STANLEY DEP SHS REPS 1/1000 PFD SER 'A'

MORGAN STANLEY DEP SHS REPR 1/1000TH INT PFD SER 'F' FX

MORGAN STANLEY DEP SHS REP 1/1000 NON-CUM PFD STK SER K

JPMORGAN CHASE & CO. 4.20% DEP SHS REPSTG 1/400TH PFD SER MM

JPMORGAN CHASE & CO. 6%NON CUM DEP SHS REP 1/400TH PFD SER EE

JPMORGAN CHASE & CO. DEP REP 1/400TH (5.75% NON CUM PFD DD)

JPMORGAN CHASE & CO. 4.625% DEP SH RE 1/400TH INT NO CU PF LL

JPMorgan Chase & Co.

JPMORGAN CHASE & CO. 4.55% DEP SHS REPSTG 1/400TH PFD SER JJ

JPMORGAN CHASE & CO. 4.75 DEP SHS REP 1/400 NCUM PFD SR GG

MKS (NASDAQ:MKSI) Price Target Raised to $355.00 at Citigroup